KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.89 $4.97 Friday, 26th Apr 2024 ALDX stock ended at $3.93. This is 0.254% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.79% from a day low at $3.83 to a day high of $3.98.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Mar 07, 2016 $4.68 $4.68 $4.68 $4.68 23 600
Mar 04, 2016 $4.50 $4.50 $4.50 $4.50 20 400
Mar 03, 2016 $4.42 $4.42 $4.42 $4.42 39 800
Mar 02, 2016 $4.50 $4.50 $4.50 $4.50 64 300
Mar 01, 2016 $4.55 $4.55 $4.55 $4.55 96 400
Feb 29, 2016 $4.90 $4.90 $4.90 $4.90 411 500
Feb 26, 2016 $3.73 $3.73 $3.73 $3.73 3 700
Feb 25, 2016 $3.58 $3.58 $3.58 $3.58 11 700
Feb 24, 2016 $3.52 $3.52 $3.52 $3.52 200
Feb 23, 2016 $3.70 $3.70 $3.70 $3.70 27 600
Feb 22, 2016 $4.03 $4.03 $4.03 $4.03 12 500
Feb 19, 2016 $4.00 $4.00 $4.00 $4.00 1 000
Feb 18, 2016 $4.00 $4.00 $4.00 $4.00 7 900
Feb 17, 2016 $4.50 $4.50 $4.50 $4.50 7 900
Feb 16, 2016 $3.82 $3.82 $3.82 $3.82 1 000
Feb 12, 2016 $3.90 $3.90 $3.90 $3.90 2 600
Feb 11, 2016 $3.90 $3.90 $3.90 $3.90 6 200
Feb 10, 2016 $4.00 $4.00 $4.00 $4.00 9 300
Feb 09, 2016 $3.70 $3.70 $3.70 $3.70 17 700
Feb 08, 2016 $3.94 $3.94 $3.94 $3.94 13 400
Feb 05, 2016 $4.15 $4.15 $4.15 $4.15 5 100
Feb 04, 2016 $4.30 $4.30 $4.30 $4.30 13 600
Feb 03, 2016 $4.26 $4.26 $4.26 $4.26 3 900
Feb 02, 2016 $4.52 $4.52 $4.52 $4.52 6 500
Feb 01, 2016 $4.80 $4.80 $4.80 $4.80 1 800
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT